Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Jan 4, 2023
Document Date
Jan 1, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.
Filer
LEBWOHL DAVID